Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P830055/S366

LCS Total Knee System

Depuy, Inc. · Decision date Jun 3, 2026

FDA DECISIONP830055/S366

What did the FDA decide?

FDA records P830055/S366 as a supplement to PMA P830055, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Jun 3, 2026.

FDA approval order statement

an increase in the maximum allowable number of baskets of product that can be processed in the cleaning and passivation tanks for Final Metal Clean Lines
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Orthopedic
Decision date
Jun 3, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P830055/S366
Regulatory pathway
PMA supplement
Applicant
Depuy, Inc.
Product code
NJL
Decision code
OK30
Decision date
Jun 3, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Prosthesis, knee, patellofemorotibial, semi-constrained, metal/polymer, mobile bearing.

Applicant
Depuy, Inc.
Product code
NJL
FDA device class
3

Review the original FDA PMA listing for the original approval scope and linked supplements.

FDA decision timeline

  1. P830055/S341 · Related supplement

    LCS(R) TOTAL KNEE SYSTEM

  2. P830055/S346 · Related supplement

    ATTUNE Revision Rotating Platform (RP) Knee System

  3. P830055/S366 received

    Application receipt date recorded by FDA.

  4. P830055/S366 · FDA decision

    30-Day Notice

  5. P830055/S360 · Related supplement

    ATTUNE Revision Knee System

  6. P830055/S370 · Related supplement

    LCS(R) TOTAL KNEE SYSTEM

  7. P830055/S369 · Related supplement

    LCS Total Knee System- ATTUNE Revision Rotating Platform Knee System

  8. P830055/S374 · Related supplement

    LCS(R) TOTAL KNEE SYSTEM, specifically ATTUNE Cruciate Retaining (CR), Posterior Stabilized (PS) and Revision Femoral C

  9. P830055/S372 · Related supplement

    ATTUNE Rotating Platform (RP) Total Knee System, ATTUNE Cementless Rotating Platform (RP) Knee System, ATTUNE Revision R

  10. P830055/S376 · Related supplement

    Attune Rotating Platform (RP) Total Knee System and the DePuy P.F.C. Sigma Rotating Platform (RP) Total Knee System an

  11. P830055/S351 · Related supplement

    Attune Revision Knee System

  12. P830055/S377 · Related supplement

    ATTUNE Rotating Platform (RP) Total Knee System, ATTUNE Revision Rotating Platform (RP) Total Knee System, and M.B.T. Re

  13. P830055/S379 · Related supplement

    ATTUNE Revision Knee System

  14. P830055/S381 · Related supplement

    ATTUNE Rotating Platform (RP) Total Knee System, and ATTUNE Revision Rotating Platform (RP) Knee System

Timeline entries are records held by MedtechLedger for P830055. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P830055

Product / regulatory recordCompanyPathwayDecision dateSource
Depuy, Inc.PMA supplementJul 18, 2025FDA
Depuy, Inc.PMA supplementAug 5, 2025FDA
Depuy, Inc.PMA supplementAug 29, 2025FDA
Depuy, Inc.PMA supplementSep 9, 2025FDA
Depuy, Inc.PMA supplementSep 26, 2025FDA
Depuy, Inc.PMA supplementNov 26, 2025FDA
Depuy, Inc.PMA supplementDec 9, 2025FDA
Depuy, Inc.PMA supplementDec 11, 2025FDA
Depuy, Inc.PMA supplementDec 15, 2025FDA
Depuy, Inc.PMA supplementDec 18, 2025FDA
Depuy, Inc.PMA supplementJan 16, 2026FDA
Depuy, Inc.PMA supplementJan 30, 2026FDA
Depuy, Inc.PMA supplementFeb 12, 2026FDA
Depuy, Inc.PMA supplementFeb 13, 2026FDA
Depuy, Inc.PMA supplementFeb 13, 2026FDA
Depuy, Inc.PMA supplementMar 27, 2026FDA
Depuy, Inc.PMA supplementApr 10, 2026FDA
Depuy, Inc.PMA supplementJun 29, 2026FDA
Depuy, Inc.PMA supplementJul 15, 2026FDA
Depuy, Inc.PMA supplementAug 5, 2026FDA
Depuy, Inc.PMA supplementAug 19, 2026FDA
Depuy, Inc.PMA supplementAug 21, 2026FDA
Depuy, Inc.PMA supplementAug 21, 2026FDA
Depuy, Inc.PMA supplementAug 27, 2026FDA
Depuy, Inc.PMA supplementSep 3, 2026FDA
Depuy, Inc.PMA supplementSep 9, 2026FDA
Depuy, Inc.PMA supplementSep 10, 2026FDA
Depuy, Inc.PMA supplementSep 21, 2026FDA
Depuy, Inc.PMA supplementSep 25, 2026FDA
Depuy, Inc.PMA supplementOct 5, 2026FDA
Depuy, Inc.PMA supplementOct 8, 2026FDA
Depuy, Inc.PMA supplementOct 9, 2026FDA
LCS Knee SystemP830055/S378
Depuy, Inc.PMA supplementOct 27, 2026FDA
Depuy, Inc.PMA supplementOct 27, 2026FDA

Explore the linked device profile

Other records with product code NJL

Product / regulatory recordCompanyPathwayDecision dateSource
Zimmer, Inc.PMA supplementOct 16, 2026FDA
Zimmer, Inc.PMA supplementSep 24, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Depuy, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
P.O. Box 988, 700 Orthopaedic Dr., Warsaw, IN, 46581

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records